A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Space Foundation Names Aspen Laser Systems, LLC as Space Certification Program Partner

February 8, 2021

Space Foundation, a nonprofit advocate organization founded in 1983, today announced Aspen Laser Systems, LLC as the most recent company to become a Space Certification partner.

Aspen Laser Systems has adapted a technology originally developed for NASA into a method of delivering noninvasive and painless light-based photobiomodulation (PBMT) therapy treatment for conditions such as arthritis, tendonitis, and acute joint or muscle injuries.

Space Certification Program awards a “seal of approval” to commercial companies that demonstrate products and services in technology, data, education and creative markets that originate from space technology and are a source of inspiration for discoveries and innovations in the global space ecosystem. Today, every community, infrastructure, and aspect of modern life is either profoundly dependent on or indirectly affected by space-related innovations.

Aspen Laser President Charles Vorwaller commented on the partnership saying, “Aspen Laser is extremely proud of our new relationship with Space Foundation. Our company and products will benefit greatly from this unique recognition, and we firmly believe that our consistent use of the Space Certification Program and official seals will expand the awareness of photobiomodulation. The Aspen Laser products are a great addition for any healthcare professional, whether experienced or just starting out with photobiomodulation.”

Carah Barbarick, space awareness programs manager at Space Foundation, also shared, “Aspen Laser Systems is an exciting addition to our Space Certification partners. With a focus on raising the standards in medical care, they are using space technology to improve the lives of all their patients, both human and animal.”

Therapeutic Technology Developed for NASA Evolved for Clinical Use

The National Aeronautics and Space Administration (NASA) became involved in research utilizing light therapy beginning in the 1990s, with many of these findings being a springboard for additional scientific and clinical studies. In 1993, Quantum Devices, Inc. developed an LED for NASA to use in their plant growth experiments. These experiments demonstrated that red LED wavelengths could boost plant growth. Coincidentally, the scientists noticed that their own skin lesions began to heal faster as well. NASA subsequently began to study the use of LED and infrared wavelengths to increase the metabolism of human cells and for medical uses to improve healing for astronauts in space.

Many medications (RX and OTC) and therapy products treat symptoms that only provide temporary relief or short-term benefits. In contrast, PBMT is a preferable treatment because it provides energy through specific wavelengths of light that penetrate inside the body and into damaged and unhealthy cells, triggering a chemical response within the cells that result in stimulating the body to heal itself.

Aspen Laser Systems, LLC was founded by Vorwaller in 2014 with the mission to provide technology for medical doctors and therapists to use in helping their patients with better pain management and a faster recovery. Aspen Laser is an FDA-registered medical device company specializing in photomedicine with a unique focus and expertise in photobiomodulation which is an alternative to pharmaceuticals and other therapeutic modalities.

According to Vorwaller, “We became aware of the research that NASA was doing in the early 1990s initially using LED low level light therapy. Today, the Aspen Laser products are the result of an evolution from this early technology. Over time, we increased the power level of the diodes, added additional infrared wavelengths, and concentrated the light output, resulting in targeted laser therapy that provides a higher concentration of light energy into an area of the body that requires it, due to localized pain or injury.”

Aspen Laser Systems’ national headquarters is based in Lindon, Utah, with an additional location in Ft. Pierce, Florida.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy